drugset / Trial / NCT03323697

Chinese Herb for the Treatment of Depression and Anxiety Disorders

NCT03323697

RandomizedParallel-groupTriple-blindTreatment

Summary

Anxiety and depression are currently among the ten most important public health concerns, and in recent years, have reached epidemic proportions. Anxiety is recognized as the main risk factor for many diseases including cardiovascular, metabolic and neuropsychiatric disorders. Current anxiolytic medications have a relatively low success rate (\~50%) and are associated with many deleterious side-effects. The investigators aim to investigate the efficacy, safety, and tolerability of a novel herbal treatment on anxiety and depression symptoms in a 6-week double-blind randomized trial.

Timeline

Start
2017-08-28
Primary completion
2018-09-01
Completion
2018-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Escitalopram Small molecule 10 mg